PL371436A1 - Terapia skojarzona z użyciem antagonisty receptora aldosteronowego i niesteroidowego środka przeciwzapalnego do profilaktyki lub leczenia zaburzeń sercowo-naczyniowych - Google Patents

Terapia skojarzona z użyciem antagonisty receptora aldosteronowego i niesteroidowego środka przeciwzapalnego do profilaktyki lub leczenia zaburzeń sercowo-naczyniowych

Info

Publication number
PL371436A1
PL371436A1 PL03371436A PL37143603A PL371436A1 PL 371436 A1 PL371436 A1 PL 371436A1 PL 03371436 A PL03371436 A PL 03371436A PL 37143603 A PL37143603 A PL 37143603A PL 371436 A1 PL371436 A1 PL 371436A1
Authority
PL
Poland
Prior art keywords
prevent
combination therapy
steroidal anti
inflammatory agent
cardiovascular disorders
Prior art date
Application number
PL03371436A
Other languages
English (en)
Inventor
Ellen G. Mcmahon
Ricardo Rocha
Amy E. Rudolph
Original Assignee
Pharmacia Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corporation filed Critical Pharmacia Corporation
Publication of PL371436A1 publication Critical patent/PL371436A1/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL03371436A 2002-01-30 2003-01-30 Terapia skojarzona z użyciem antagonisty receptora aldosteronowego i niesteroidowego środka przeciwzapalnego do profilaktyki lub leczenia zaburzeń sercowo-naczyniowych PL371436A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35300802P 2002-01-30 2002-01-30

Publications (1)

Publication Number Publication Date
PL371436A1 true PL371436A1 (pl) 2005-06-13

Family

ID=27663163

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03371436A PL371436A1 (pl) 2002-01-30 2003-01-30 Terapia skojarzona z użyciem antagonisty receptora aldosteronowego i niesteroidowego środka przeciwzapalnego do profilaktyki lub leczenia zaburzeń sercowo-naczyniowych

Country Status (10)

Country Link
EP (1) EP1469884A1 (pl)
JP (1) JP2005521665A (pl)
KR (1) KR20040078683A (pl)
CN (1) CN1625412A (pl)
BR (1) BR0307342A (pl)
CA (1) CA2473797A1 (pl)
MX (1) MXPA04007128A (pl)
PL (1) PL371436A1 (pl)
WO (1) WO2003063908A1 (pl)
ZA (1) ZA200405829B (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2005112247A (ru) * 2002-09-25 2006-01-20 Форбз Меди-Тек Инк. (Ca) Новые структуры и композиции, содержащие стеролы и/или станолы и определенные классы противовоспалительных средств, и их применение для лечения или предупреждения сердечно-сосудистого заболевания, лежащих в его основе состояний, включая гиперлипидемию, и других нарушений, при которых воспаление является частью их этиологии или проявления
US8487128B2 (en) * 2002-11-26 2013-07-16 Chs Pharma, Inc. Protection of normal cells
WO2006102439A2 (en) 2005-03-23 2006-09-28 Florida Atlantic University Treatment or prevention of cancer and precancerous disorders
WO2014160702A1 (en) 2013-03-25 2014-10-02 Chs Pharma, Inc. Retinopathy treatment

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5550124A (en) * 1991-12-10 1996-08-27 University Of Southern California Use of peripheral-type benzodiazpine sites for treatment of CNS trauma or disease
EP0757558A4 (en) * 1994-04-12 1999-06-16 Alza Corp METHOD FOR DETECTING AGENTS THAT MODULATE AN INFLAMMATORY SKIN REACTION
WO1996024358A1 (en) * 1995-02-10 1996-08-15 G.D. Searle & Co. Use of low dose amount of spironolactone for treatment of cardiovascular disease
WO2000010552A2 (en) * 1998-08-24 2000-03-02 Global Vascular Concepts, Inc. Use of anti-angiogenic agents for inhibiting vessel wall injury
UA74141C2 (uk) * 1998-12-09 2005-11-15 Дж.Д. Сірл Енд Ко. Фармацевтична композиція на основі тонкоподрібненого еплеренону (варіанти), спосіб її одержання та спосіб лікування розладів, опосередкованих альдостероном (варіанти)
JP2004505060A (ja) * 2000-07-27 2004-02-19 ファルマシア・コーポレーション 炎症関連心臓血管障害を防止するかまたは治療するためのアルドステロンアンタゴニストおよびシクロオキシゲナーゼ−2阻害剤併用療法

Also Published As

Publication number Publication date
WO2003063908A1 (en) 2003-08-07
CA2473797A1 (en) 2003-08-07
CN1625412A (zh) 2005-06-08
ZA200405829B (en) 2005-10-21
MXPA04007128A (es) 2005-03-31
EP1469884A1 (en) 2004-10-27
BR0307342A (pt) 2004-12-21
KR20040078683A (ko) 2004-09-10
JP2005521665A (ja) 2005-07-21

Similar Documents

Publication Publication Date Title
HK1215265A1 (zh) α相關疾病的治療
EP1489915A4 (en) TREATMENT AND PREVENTION OF INFLAMMATORY DISORDERS
HK1079203A1 (en) Substituted amine derivatives and methods of use in the treatment of angiogenesis related disorders
PT2075000E (pt) Combinação de azelastina e ciclesonida
IL162838A0 (en) Compositions and methods for prevention and treatment peptide-of amyloid- related disorders
HK1073997A1 (en) Administration of agents for the treatment of inflammation
AU2003213787A1 (en) Compositions and methods for the treatment of anorectal disorders
AU2003291480A8 (en) Composition for the prevention and treatment of inflammation of the ear
IL145237A0 (en) Combination therapy of angiotensin converting enzyme inhibitor and epoxy-steroidal aldosterone antagonist for treatment of cardiovascular disease
EP1406648A4 (en) USE OF ANGIOTENSIN I DERIVATIVE AGENT FOR THE TREATMENT AND PREVENTION OF INFECTIOUS HEART DAMAGE AND DISEASES
GB0615918D0 (en) Composition and its therapeutic use
PL371436A1 (pl) Terapia skojarzona z użyciem antagonisty receptora aldosteronowego i niesteroidowego środka przeciwzapalnego do profilaktyki lub leczenia zaburzeń sercowo-naczyniowych
GB0207410D0 (en) Compounds and their therapeutic use
WO2002009759A3 (en) Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders
AU2003250831A8 (en) Use of hec1 antagonists in the treatment of proliferative disorders and cancer
EP1534293A4 (en) INFLAMMATORY COMPOSITIONS AND METHODS OF ADMINISTRATION
IL166062A0 (en) Compositions and methods for therapeutic treatment
AU2003241346A8 (en) Therapeutic compositions comprised of pentamidine and methods of using same to treat cancer
IL164169A (en) Non-steroidal progesterone receptor modulator compounds and their use in therapy
EP1539100A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF SKIN DISORDERS
AU2003270540A8 (en) Treatment of cyclooxygenase-3 mediated diseases and disorders
PL373391A1 (pl) Terapia blokerem aldosteronu w profilaktyce lub leczeniu zaburzeń związanych z zapaleniem
GB0419828D0 (en) The treatment of inflammatroy disorders and pain
GB0305699D0 (en) Therapeutic compositions and methods
EP1557169A4 (en) THERAPEUTIC AND / OR PROPHYLACTIC AGENT FOR DYSCHEZIA

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)